Skip to main content

Table 1 Expression constructs for human ZHXs

From: Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains

Protein

Construct OPPF_

Domain/s

aa range

5' primer

3' primer

Vector

Tag

ZHX1

1610

Full-length

1-874

ATGGCAAGCAGGCGAAAATCAAC

TCAGTCATCTGATTTAGACAGCTTCCG

pDEST14

N-His

 

1611

HD1

284-343

AATAGCATTCCCACCTACAATGCTGC

CCAACTAACACCATGTTTTAAACGTTGGGC

pDEST14

N-His

 

1612

HD3

556-633

CAGCCTAAGCAATCCTGGAATCC

ATCTATTTCCATTTTCTCTTCCTTTAAAGCTTTTG

pDEST14

N-His

 

1613

HD4

655-731

GCACCTAAGTCAGGGAGTACAGGCAAG

TGAATTGGCGCTCTGATAGTAGTAGTACCATTTC

pDEST14

N-His

 

1614

HD5

770-824

GACAGGGGACCATCACTCATAAAATTTAAAAC

TCTTCTCTGTCTTTCTGCAAACCACTCTCTG

pDEST14

N-His

 

1615

HD3-4

556-731

CAGCCTAAGCAATCCTGGAATCC

TGAATTGGCGCTCTGATAGTAGTAGTACCATTTC

pDEST14

N-His

 

1616

HD1-5

284-824

AATAGCATTCCCACCTACAATGCTGC

TCTTCTCTGTCTTTCTGCAAACCACTCTCTG

pDEST14

N-His

 

1632

2ZF

60-153

AATCAGCAAAATAAAAAAGTTGAAGG

AAAAGTCAGATCATTTATTGTTTGTTC

pDEST14

N-His

 

1633

2ZF

55-156

TCTGTGGATTCAGACAATCAGC

ACTACCATCAAAAGTCAGATCATTTATTG

pDEST14

N-His

 

1634

HD2

464-523

TCATTTGGCATTCGGGCAAAAAAGAC

CTTTGAATTTCTCTGGTTGTACCTTGTG

pDEST14

N-His

 

1635

HD2-3

464-633

TCATTTGGCATTCGGGCAAAAAAGAC

ATCTATTTCCATTTTCTCTTCCTTTAAAGCTTTTG

pDEST14

N-His

 

1636

HD2-4

464-731

TCATTTGGCATTCGGGCAAAAAAGAC

TGAATTGGCGCTCTGATAGTAGTAGTACC

pDEST14

N-His

 

1637

HD2-5

464-824

TCATTTGGCATTCGGGCAAAAAAGAC

TCTTCTCTGTCTTTCTGCAAACCACTCTCTG

pDEST14

N-His

 

2264

HD3

556-633

CAGCCTAAGCAATCCTGGAATCC

ATCTATTTCCATTTTCTCTTCCTTTAAAGCTTTTG

pOPINF

N-His -3C

 

2265

HD4

655-731

TCTGTGGATTCAGACAATCAGC

TTCTATACCTAATTCTGATCTTCTCTGTC

pOPINF

N-His -3C

 

2465

All

55-830

TCTGTGGATTCAGACAATCAGC

TTCTATACCTAATTCTGATCTTCTCTGTC

pOPINF

N-His -3C

ZHX2

2268

2ZF

60-158

GTGATAGAGGTGAAATCTATGGG

GGTTTCGATGGACTGTTCCAAG

pDEST14

N-His

 

2269

HD1

267-321

TACAACTCTGCCCTGGATACAA

CCAGCTGATGCCATGCTTTAAG

pDEST14

N-His

 

2270

HD2

444-500

CGCAAGAAGACAAAGGAGCAG

GTGGACGATGCCCCTTTGAC

pDEST14

N-His

 

2271

HD3

530-582

CCCCAGAAGTTCAAAGAGAAAAC

CTTCCGCCTCTCCGAGAACC

pDEST14

N-His

 

2272

HD4

635-686

AAAAGTCAAGAACAGGTTCATCTC

TCCCGTTTTCAGCAAGCATCTG

pDEST14

N-His

 

2273

HD2-3

444-582

CGCAAGAAGACAAAGGAGCAGA

CTTCCGCCTCTCCGAGAACC

pDEST14

N-His

 

2466

All

55-745

TCCAAAGAAAACGAAGTGATAGAGGTGAAATC

CAACTTCTCCAAGTCCTCTTCGCAG

pOPINF

N-His -3C

ZHX3

2274

2ZF

66-153

AATGGGCATCGGAGCACTTTAG

CTGCTCCACAACCACATGATTG

pDEST14

N-His

 

2275

HD1

306-363

ATTCCAACGTACAATGCAGCC

CCAGCTGATCCCCTGCTTCAG

pDEST14

N-His

 

2276

HD2

500-553

AAGAAATCTCATGAACAGCTGTCAG

CTTCAAGTTCCGGCAGTGGTATC

pDEST14

N-His

 

2277

HD3

621-664

CCTGAGCAGCTCAGAGCC

CCGTCTCTCTGAAAACCAGC

pDEST14

N-His

 

2278

HD4

758-826

AAACTGGCAGAGCAGCTCC

CCATTTGAGTTGGCCGTTCTTC

pDEST14

N-His

 

2279

HD2-3

500-664

AAGAAATCTCATGAACAGCTGTCAG

CCGTCTCTCTGAAAACCAGC

pDEST14

N-His

 

2467

All

61-966

GGCTCTACACTGGCCAATGGGC

AGGTAAAGGAAAGGTCCTACATTGTGGG

pOPINF

N-His -3C

  1. For the primers only the regions homologous to the target sequence are shown. 5' primers had GGGGACAAGTTTGTAC
  2. CCAAAAAAGCAGGCTTCGAAGGAGATAGAACCATGGCACATCACCACCACCATCAC and AAGTTCTGTTTCAGGGCCCG 5' extensions, while 3' primers had GGGG
  3. ACCACTTTGTACAAGAAAGCTGGGTCTCA and ATGGTCTAGAAAGCTTTA 5' extensions for cloning into pDEST14 or pOPINF vectors using either Gateway technology or the Infusion cloning system respectively.